Berry (US:BERY) ZACKS·2024-11-19 15:30Core Insights - Berry Global reported revenue of $3.17 billion for the quarter ended September 2024, marking a year-over-year increase of 2.6% and exceeding the Zacks Consensus Estimate of $3.15 billion by 0.56% [1] - The company's EPS for the same period was $2.27, slightly down from $2.28 a year ago, and surpassed the consensus estimate of $2.25 by 0.89% [1] Revenue Performance - Net Sales in Health, Hygiene & Specialties reached $642 million, slightly above the average estimate of $641.13 million, reflecting a year-over-year increase of 1.9% [3] - Net Sales in Flexibles amounted to $687 million, exceeding the estimated $683.03 million, with a year-over-year change of 2.4% [3] - Net Sales in Consumer Packaging for North America were $840 million, surpassing the average estimate of $818.29 million, representing a significant year-over-year increase of 6.9% [3] - Net Sales in Consumer Packaging for International markets totaled $999 million, slightly below the estimated $995.96 million, showing a minor decline of 0.1% year over year [3] Operating EBITDA Performance - Operating EBITDA for Health, Hygiene & Specialties was reported at $79 million, below the average estimate of $88.81 million [3] - Operating EBITDA for Consumer Packaging in North America was $171 million, slightly below the estimated $172.18 million [3] - Operating EBITDA for Consumer Packaging in International markets reached $186 million, exceeding the average estimate of $184.88 million [3] - Operating EBITDA for Flexibles was reported at $110 million, significantly lower than the average estimate of $126.26 million [3] Stock Performance - Over the past month, shares of Berry Global have returned -3.3%, contrasting with the Zacks S&P 500 composite's increase of 0.6% [4] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market in the near term [4]